Deutsche Bank Aktiengesellschaft reaffirmed their buy rating on shares of Oxford Nanopore Technologies (LON:ONT – Free Report) in a research note issued to investors on Thursday morning, MarketBeat Ratings reports. Deutsche Bank Aktiengesellschaft currently has a GBX 195 price target on the stock.
ONT has been the subject of a number of other reports. Peel Hunt reissued a “hold” rating and issued a GBX 153 target price on shares of Oxford Nanopore Technologies in a research note on Monday, July 13th. Citigroup lowered Oxford Nanopore Technologies to a “buy” rating in a research report on Monday, July 20th. Royal Bank Of Canada reiterated an “outperform” rating and set a GBX 225 price objective on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Finally, Berenberg Bank cut their price objective on Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a “buy” rating on the stock in a report on Wednesday. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of GBX 193.25.
Read Our Latest Stock Report on ONT
Oxford Nanopore Technologies Trading Up 3.3%
Oxford Nanopore Technologies (LON:ONT – Get Free Report) last released its quarterly earnings data on Wednesday, August 19th. The company reported GBX (4.90) EPS for the quarter. Oxford Nanopore Technologies had a negative net margin of 54.66% and a negative return on equity of 35.45%.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Read More
- Five stocks we like better than Oxford Nanopore Technologies
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
